# ClinicalTrials.gov record NCT01524705

> PeptideScanner retained ClinicalTrials.gov record NCT01524705 at 2026-07-30T19:03:45.487Z. Its registry update date was 2023-12-29, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct01524705-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-12-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01524705-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01524705-exenatide-v1.json
- Content SHA-256: `98aba4fad2b6a38ea187755769ed36961367f014adce4d1c48f2a00ff788fdea`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01524705 ([`ctg-observation-nct01524705-2023-12-29-6156cb47a64d`](#source-ctg-observation-nct01524705-2023-12-29-6156cb47a64d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01524705 at 2026-07-30T19:03:45.487Z. Its registry update date was 2023-12-29, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01524705-2023-12-29-6156cb47a64d`](#source-ctg-observation-nct01524705-2023-12-29-6156cb47a64d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01524705 at 2026-07-30T19:03:45.487Z. Its registry update date was 2023-12-29, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01524705-2023-12-29-6156cb47a64d`](#source-ctg-observation-nct01524705-2023-12-29-6156cb47a64d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01524705-2023-12-29-6156cb47a64d`](#source-ctg-observation-nct01524705-2023-12-29-6156cb47a64d))

## Sources

<a id="source-ctg-observation-nct01524705-2023-12-29-6156cb47a64d"></a>
- **ClinicalTrials.gov record NCT01524705 · retained source version 2023-12-29:6156cb47a64d712f6d5b831c269d2e06248288d5b2f1368296d2d219897bf42d** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01524705) (`ctg-observation-nct01524705-2023-12-29-6156cb47a64d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01524705." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01524705-exenatide-v1.json SHA-256: 98aba4fad2b6a38ea187755769ed36961367f014adce4d1c48f2a00ff788fdea.